✦ LIBER ✦

S-1 vs. Gemcitabine as an Adjuvant Therapy after Surgical Resection for Ductal Adenocarcinoma of the Pancreas

✍ Scribed by Okabayashi, Takehiro; Shima, Yasuo; Iwata, Jun; Morita, Sojiro; Sumiyoshi, Tatsuaki; Kozuki, Akihito; Tokumaru, Teppei; Iiyama, Tatsuo; Kosaki, Takuhiro; Kobayashi, Michiya; Hanazaki, Kazuhiro

Book ID: 127336738
Publisher: Springer
Year: 2014
Tongue: English
Weight: 715 KB
Volume: 38
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s00268-014-2703-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Adjuvant Gemcitabine Plus S-1

Impact of Adjuvant Gemcitabine Plus S-1 Chemotherapy After Surgical Resection for Adenocarcinoma of the Body or Tail of the Pancreas

✍ Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Ha 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 172 KB

Loco-recurrence after resection for duct

Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: Predictors and implications for adjuvant chemoradiotherapy

✍ Frampton, A.E.; Zhang, Y.; Kyriakides, C.; Bong, J.J.; Habib, N.A.; Ahmad, R.; J 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 45 KB

W1671 Prognostic Impact of Dihydropyrimi

W1671 Prognostic Impact of Dihydropyrimidine Dehydrogenase Expression in Adjuvant Gemcitabine Plus S-1 Chemotherapy After Surgical Resection for Pancreatic Adenocarcinoma

✍ Kondo, Naru; Murakami, Yoshiaki; Uemura, Kenichiro; Hayashidani, Yasuo; Sudo, Ta 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Prognostic Impact of Dihydropyrimidine D

Prognostic Impact of Dihydropyrimidine Dehydrogenase and Human Equilibrative Nucleoside Transporter 1 Expression in Adjuvant Gemcitabine Plus S-1 Chemotherapy After Surgical Resection for Pancreatic Adenocarcinoma

✍ Kondo, Naru ;Murakami, Yoshiaki ;Uemura, Kenichiro ;Sudo, Takeshi ;Hashimoto, Ya 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 187 KB